跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Capmerin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Capmerin
Approved
STANDARD
Capmerin
Korea United Pharm Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f6e696a1d8a1c3a6
Company
Korea United Pharm Inc.
Type
Standard
Approval Details
Approval Id
f6e696a1d8a1c3a6
Drug Approval Philippines Name
Capmerin
Product Name
Capmerin
Registration Number
DR-XY30497
Brand Name
Capmerin
Generic Name
Mercaptopurine
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Korea United Pharm Inc.
Importer
Qualimed Pharma Inc.
Distributor
Qualimed Pharma Inc.
Company Detail Path
/organization/korea-united-pharm-inc
Issuance Date
25 July 2024
Expiry Date
02 February 2030
Pharmacologic Category
Antineoplastic (Cell Cycle-Specific Agent)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f6e696a1d8a1c3a6
Type
Standard
Back to Philippines FDA Approvals